Literature DB >> 19586666

Cervicofacial nontuberculous mycobacterium lymphadenitis in children: is surgery always necessary?

Robert L Harris1, Prince Modayil, Jane Adam, Michael Sharland, Paul Heath, Timothy Planche, Hamid Daya.   

Abstract

INTRODUCTION: The optimal treatment of cervicofacial nontuberculous mycobacterium lymphadenitis (CFNTB) in children is yet to be established. There is a general consensus that surgical excision results in a definitive resolution of the disease. The main aim of surgery is to remove affected nodes so that they do not discharge through the skin. Recently there are some investigators who are reporting successful antibiotic treatment and advocating medical therapy as the first line treatment.
METHODS: 16 children consecutively presenting to otolaryngology in a tertiary referral centre over an 8-year period with CFNTB. Inclusion criteria were chronic cervicofacial lymphadenitis with either: (1) a culture positive for atypical mycobacteria (from either a lymph node or fine needle aspirate (FNA) specimen); or (2) acid-fast bacilli identified (from either a lymph node or FNA specimen); or (3) post excision histological findings consistent with mycobacterial infection (i.e. non-caseating granulomas) in the absence of other clinical features suggestive of other granulomatous conditions. Lesions with superficial skin change were treated preferentially with surgery. Children presenting with lymph nodes contained deep to sternocleidmastoid were assessed with FNA cytological and microbiological analysis and MRI or CT, and treated preferentially with antibiotics or watchful waiting.
RESULTS: 4 children (2 culture positive, 2 with acid-fast bacilli on needle aspirate) presented with lymphadenopathy deep to sternocleidmastoid and were managed non-surgically. All 4 resolved without cutaneous involvement. 11 children with a clinical presentation of CFNTB underwent complete excision of all involved nodes for superficial lesions (6 were culture positive, and all had granulomatous histology). None recurred. 1 patient presented late with a mature, discharging parotid sinus, which was managed with watchful waiting as the lesion was clinically close to natural resolution.
CONCLUSIONS: Depth at presentation may help decide which patients with CFNTB can be treated non-surgically without cutaneous sequelae. We propose that a watch and wait management is an option for deep nodes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19586666     DOI: 10.1016/j.ijporl.2009.06.006

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  6 in total

1.  Atypical mycobacteriosis in children: a diagnostic and therapeutic challenge.

Authors:  C M C Deichmueller; K Emmanouil; H-J Welkoborsky
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-03       Impact factor: 2.503

2.  [Surgical treatment of children with nontuberculous mycobacteria cervical lymphadenitis].

Authors:  V M Hofmann; M Khan; H Olze; R Krüger; A Pudszuhn
Journal:  HNO       Date:  2014-08       Impact factor: 1.284

Review 3.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

Review 4.  Salivary gland diseases in children.

Authors:  Heinrich Iro; Johannes Zenk
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2014-12-01

5.  A case of axillary lymphadenitis caused by Mycobacterium intracellulare in an immunocompetent patient.

Authors:  Junko Itano; Kadoaki Ohashi; Satoru Senoo; Naohiro Oda; Kazuya Nishii; Akihiko Taniguchi; Nobuaki Miyahara; Yoshinobu Maeda; Katsuyuki Kiura
Journal:  Respir Med Case Rep       Date:  2019-10-14

Review 6.  Surgical treatment of non-tuberculous mycobacterial lymphadenitis in children: Our experience and a narrative review.

Authors:  Sara Torretta; Michele Gaffuri; Tullio Ibba; Pasquale Capaccio; Paola Marchisio; Antonella Maruca; Samantha Bosis; Lorenzo Pignataro
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.